UnitedHealth Group faces structural headwinds, political risks, and a sluggish recovery despite being undervalued. Learn more ...

Wedgewood Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second-quarter ...

L1 Capital, an investment management firm, released its “L1 Capital International Fund” (unhedged) second quarter 2025 ...

UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

UnitedHealth Group (UNH) closed the most recent trading day at $282.65, moving -1.88% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.01%. Meanwhile ...

UnitedHealth delays Q2 report to July 29 as insurer earnings season begins with cost pressures clouding 2025 outlooks across ...

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group( UNH ...

UnitedHealth extended its 15-year earnings beat streak in 2024 with $3.3 billion in asset sales, raising questions about ...

According to a recent SEC filing, Ayrshire Capital Management LLC fully liquidated its holding in UnitedHealth Group. The ...

UnitedHealth Group Incorporated (NYSE: UNH) is one of the stocks on Jim Cramer’s radar. A caller mentioned the stock and said ...

The revised price target follows statements made by UnitedHealth’s reinstated CEO during the company’s annual meeting on June ...